![]() |
|
|
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
From Departments of Clinical Pharmacology (K.N., S.T., A.K., K.S., A.F.) and Pharmacology (M.S., M.I.), Jichi Medical School, Minamikawachi, Tochigi, Japan; and Department of Pediatrics (G.J.S.), University of Rochester School of Medicine and Dentistry, Rochester, New York
Received July 18, 2002; accepted October 22, 2002.
| Abstract |
|---|
|
|
|---|
prepulse and basolateral sodium
removal, respectively. Apical NHE activity was greater in 8 to 9 week old
hypertensive SHR compared with WKY. Although Y-27632 suppressed pHi
recovery in both strains, sensitivity was 50-fold higher in adult SHR. Y-27632
suppressed basolateral NHE in both strains with similar sensitivity. Apical
NHE activity was not greater in 5-week-old, not yet hypertensive, SHR rats
compared with WKY. In clearance studies, Na excretion was less in SHR than in
WKY rats. Y-27632 increased Na excretion and fractional excretion Na in both
strains but more so in SHR. 22Na uptake of the brush border
membrane vesicle taken from Y-27632-treated rats decreased more than that from
vehicle-treated animals in both adult SHR and WKY. We conclude that apical NHE
activity is increased in SHR PCT compared with controls and that inhibition of
Rho-kinase reduces PCT NHE activities and causes natriuresis.
The state of the cytoskeleton situated beneath the cell membrane can
modulate activities of sodium transporters located on the membrane
(Mills et al., 1994
;
Hamm-Alvarez and Sheetz, 1998
).
Shrinkage of the cell increases NHE activity in astrocytes by modulating
myosin light chain kinase (Shrode et al.,
1995
). The state of actin organization modulates trafficking of
NHE3 protein and thereby changes its activity in renal proximal tubular cells
(Chalumeau et al., 2001
).
Furthermore, Kurashima et al.
(1999
) reported using CHO
cells transfected with NHE3 and that the NHE3 requires an intact actin
cytoskeleton to maintain its usual function.
Small GTP-binding proteins of Rho family (Rho, Rac, and Cdc40) are among
the regulators of the actin cytoskeleton
(Hall, 1998
). Systemic
inhibition of p160ROCK (a Rho-associated coil-forming protein kinase)
(Hirata et al., 1992
) by
administration of a selective inhibitor, Y-27632, lowers blood pressure by the
disruption of the cytoskeleton and inhibition of NHE1 activity in vascular
smooth muscle cells, leading to the reduction in arterial resistance
(Uehata et al., 1997
). We have
recently reported in neutrophils that Y-27632 inhibited superoxide anion
production (Kawaguchi et al.,
2000
). Furthermore, myosin light chain phosphorylation by
Rho-kinase is a prerequisite for normal NHE3 function in transfected CHO cells
(Szaszi et al., 2000
). Thus,
it is possible that NHE may play a significant role in modulating blood
pressure via Rho-kinase mediated mechanisms. It remains to be determined,
however, whether the Rho-kinase actually affects intact NHE3 in native renal
tubular cells and subsequent Na/fluid balance in the body.
The purpose of this study was as follows: 1) to examine the contribution of
p160ROCK to maintaining NHE3 and NHE1 activities in rat isolated perfused
proximal convoluted tubule cells in vitro by using a selective inhibitor
Y-27632; 2) to compare this contribution in young (not yet hypertensive)
(Yamori, 1974
) and adult
(hypertensive) rats; 3) to determine the effect of Y-27632 on urine volume and
sodium excretion by an in vivo clearance study; and finally 4) to compare the
roles of inhibiting p160ROCK in SHR versus control animals.
| Materials and Methods |
|---|
|
|
|---|
In Vitro Microperfusion. In vitro perfusion of isolated proximal
convoluted (S1) tubule was performed in accordance with Burg et al.
(1966
), as modified in our
laboratory (Tsuruoka et al.,
2000
,
2001
). In brief, animals were
anesthetized with intraperitoneal injection of pentobarbital sodium. The left
kidney was removed and coronal slices were made. The slices were transferred
to a chilled solution of the following composition: 14 mM
KH2PO4, 44 mM K2HPO4, 15 mM KCl, 9
mM NaHCO3, and 160 mM sucrose with pH 7.4. S1 segments with length
ranging from 0.25 to 0.35 mm were dissected from the superficial labyrinth by
fine forceps under stereomicroscope at 4°C. We dissected and used three to
eight proximal tubules from each animal. Isolated tubules were transferred to
a perfusion chamber mounted on an inverted microscope and perfused in vitro at
37°C. Tubules were hooked up to the holding pipette, and a single-barreled
perfusion pipette was inserted into the tubular lumen. Triple-barreled
polyethylene tubing was inserted into the perfusion pipette to allow rapid
exchange of the perfusion fluid. The perfusion rate was controlled at 10 to 20
nl/min by adjusting the height of the fluid reservoir, which was connected to
the back-end of the perfusion pipette. A flow-through bath system was used to
allow rapid exchange of bathing fluid. The bath fluid was maintained at
37°C. The flow rate of bath fluid was 3 to 5 ml/min, which allowed the
bath fluid to be exchanged within 2 s. The composition of the bicarbonate-free
solution for perfusing and bathing solutions in this study was as follows: 135
mM NaCl, 5 mM KCl, 1.6 mM Na2HPO4, 0.4 mM
NaH2PO4, 1.8 mM CaCl2, 1 mM MgCl2,
10 mM HEPES, 5.6 mM glucose, and 5 mM L-alanine at pH 7.4 and 293 ± 3
mOsm/kg. For the
prepulse solution,
40 mM NaCl of the bicarbonate-free solution was replaced by
NH4Cl.
Measurement of Intracellular pH. Acetoxymethyl ester of 2',7'-bis(carboxyethyl) carboxyfluorescein (BCECF-AM) was used as an indicator of intracellular pH (pHi). BCECF-AM was added to the bicarbonate-free solution from a stock solution (1 mM in dimethyl sulfoxide) to a final concentration of 1 µM. After the microperfused tubule was stabilized for 15 min, BCECF-AM was added to the bathing solution, and the tubules were incubated for about 20 min. Then, BCECF was removed from the bathing solution, and the experiments were started.
Measurement of intracellular pH was performed by a fluorescence ratio
imaging technique using an Olympus OSP system (Olympus Optical, Tokyo, Japan),
as described previously (Tsuruoka et al.,
1993
,
2001
). Measurements were done
at 400x magnification; the diameter of the beam of light focused on the
tubule was 25 µm. BCECF fluorescence was measured at an emission wavelength
of 530 nm in response to excitation wavelengths of 490 and 440 nm.
Autofluorescence-corrected fluorescence ratio values (490/440 nm) were
calculated by the apparatus every 1 s. We used only the tubules showing at
least 20-fold greater intensity than that of background. To minimize
photobleaching and cell damage, the duration of each experiment was made as
short as possible. BCECF fluorescence was calibrated using the nigericin/high
K method, and fluorescence ratios were converted to pH units, as described
previously (Thomas et al.,
1979
).
Measurement of Apical and Basolateral NHE Activities. Apical NHE
activity of the cell was assessed by the H-ATPase-independent pHi
recovery rate (dpHi/dt) after intracellular acid loading in basal
bicarbonate-free solution under the luminal presence of 5 nM bafilomycin A1, a
specific inhibitor of the vacuolar H-ATPase
(Dagher and Sauterey, 1992
;
Tsuruoka and Schwartz, 1997
).
The acid load was accomplished by the
prepulse; after 5 min of exposure
to 40 mM NH4Cl, the ammonium was rapidly removed. The initial rate
of recovery (dpHi/dt) at around pHi 7.0 was used for the
evaluation (Fig. 1). To
calculate the initial dpHi/dt, a regression line was obtained using
StatView software (SAS Institute, Inc., Cary NC). We monitored
dpHi/dt for more than 7 min after the
pulse to determine the initial
slope. From the increase in pHi over 50 s, the initial slope was
calculated. It took approximately 45 min from initiation of the perfusion to
termination of the pHi monitoring.
|
Preliminary studies confirmed that the bafilomycin A1-insensitive
pHi recovery was completely abolished by concomitant addition of
amiloride (1 mM) to lumen, which was previously used for the evaluation of the
activity (Hayashi et al.,
1997
). Thus, the bafilomycin A1-insensitive pHi
recovery was comparable to the amiloride-inhibitable pHi recovery
after the
prepulse. Vehicle (water)
or a concentration of Y-27632 was added with bafilomycin A1 10 min before the
initiation of the
prepulse.
Basolateral NHE activity was determined by the change of pHi
following the removal of Na from bathing solution
(Geibel et al., 1989
). The
pHi stabilized within 3 min after this maneuver. We have previously
confirmed that this change of pHi was completely abolished by
concomitant addition of amiloride (10 µM) to the bath
(Tsuruoka et al., 1993
).
During these experiments we perfused with a Na-free solution for the time that
Na was removed from the basolateral solution
(Hayashi et al., 1997
).
In Vivo Clearance Study. The in vivo clearance study was performed
as reported by Kawaguchi et al.
(2001
) from our laboratory. In
brief, the animals were anesthetized using Inactin (BYK Gulden, Konstanz,
Germany; 100 mg/kg, i.p.) and a tracheostomy performed. The femoral artery was
cannulated with PE-10 tubing, which was connected to PE-50 tubing for blood
sampling and blood pressure monitoring under anesthesia. The femoral vein was
cannulated for infusion of medications and agents. Thereafter, bladder
puncture was performed by insertion of PE-50 tubing after urethral ligation;
animals with gross hematuria were discarded. Inulin (0.5% in saline) was
continuously infused at 55 µl/min. After an equilibration period of 90 min,
urine was collected during two successive 60-min periods (from 90 to 150 min
and 210 to 270 min). The first period was considered the control period and
the second period as the experimental one. This latter period began just after
the first urinary collection (150 min) with a continuous infusion of Y-27632
(0.8 mg/kg/h; generous gift from Yoshitomi Pharmaceutical Co. Ltd., Osaka,
Japan) or vehicle. The infusion continued until the end of the study (270
min). In preliminary studies, we found that this infusion rate of Y-27632 was
the maximum dose that could be given without a reduction in systemic blood
pressure. We carefully monitored mean arterial blood pressure during the
study, and an experiment was discarded when the mean blood pressure decreased
more than 5% of the basal level. Blood sampling (200 µl) was performed at
the midpoint of each urine collection period; an equal volume of saline was
injected to offset the loss of blood. Concentrations of inulin, Na, K, and
creatinine were measured from both urine and serum specimens. Inulin
concentration was determined by modified anthrone method and concentrations of
Na and K were measured by an Auto-Analyzer. Data for urinary sodium excretion
(milliequivalent per hour per 100 g b.wt.), fractional excretion of sodium and
potassium (FE Na and FE K, in percentages), and GFR (milliliter per minute per
100 g b.wt.) were generated from standard calculations.
22Na Uptake Study with Brush-Border Membrane Vesicle.
Brush-border membrane vesicle (BBMV) was prepared from the renal cortex of
adult WKY and SHR. 22Na uptake studies were performed according to
Morduchowicz et al. (1989
). In
brief, purified BBMV were prepared by Mg2+ precipitation
method from SHR and WKY treated with Y-27632 or vehicle in vivo. The way of
treatment was similar with in vivo clearance study mentioned above. Transport
study using 22Na was performed at room temperature by a Millipore
rapid-filtration procedure. 22Na uptake was measured in the
presence of an outward H+ gradient induced by preincubation of
medium (273 mM mannitol, 10 mM MgSO4, 9 mM Tris, 14 mM HEPES, and
30 mM MES, pH 6.0). Uptake was initiated by incubation of vesicles with medium
(1 mM 22NaCl, 286 mM mannitol, 2 mM MgSO4, 13 mM Tris,
15 mM HEPES, 6 mM MES, pH 7.5) and was stopped on ice-cold isosmotic solution.
The uptake was increased with time until 30 s. To evaluate initial uptake
rate, we measured the uptake at 5 and 15 s after initiation of the incubation.
Protein concentration was measured by Coomassie brilliant blue with bovine
serum albumin as the reference protein. The initial 22Na uptake
rate was expressed in moles per milligram protein per 5 s
(Morduchowicz et al.,
1989
).
Statistical Analysis. Data are expressed as the mean ± S.E. Statistical analysis was performed by two-way analysis of variance and repeated measures approach when necessary. Significance was asserted when P < 0.05.
| Results |
|---|
|
|
|---|
Apical NHE Activity Is Reduced by the Inhibition of Rho-Kinase
Activity. Figure 1A shows a
representative tracing of pHi recovery before and after the
prepulse, during which bafilomycin
A1 was present in the perfusate, in proximal convoluted tubule cells of adult
WKY rats. The pHi under basal conditions was 7.33 ± 0.03 pH
units (n = 82 cells). After the
prepulse, the pHi
decreased to
7.0 and rapidly recovered. The dpHi/dt was 60
± 8 x 102 pH units/s (n =
8; Fig. 2A, vehicle). Treatment
with 107 M Y-27632 significantly reduced
dpHi/dt recovery from the acid load
(Fig. 1B), and this was evident
in a concentration-dependent manner (Fig.
2A). The mean value at 1 x 106
M was 10 ± 8 x 102 pH units/s
(n = 7; Fig. 2A).
Figure 2B shows a 75% reduction
of apical Na-H activity at 107 M.
|
In proximal convoluted tubule cells from SHR, the pHi recovery was significantly greater than that in the age-matched WKY (a representative tracing is shown in Fig. 1C). The mean value for dpHi/dt was 95 ± 15 x 102 pH units/s (n = 70). Y-27632 also significantly suppressed the dpHi/dt (Fig. 1D) in a concentration-dependent manner in SHR (Fig. 2A), and the sensitivity to the drug as determined by the 50% reduction (percent reduction) was about 50-fold greater than that in WKY (Fig. 2B).
We evaluated pHi recovery in proximal tubule cells of young SHR and WKY rats. Basal dpHi/dt was 59 ± 10 x 102 and 42 ± 10 x 102 pH units/s in SHR and WKY, respectively, and there was no significant difference between the two groups (P = 0.08, n = 60; Fig. 2C). Treatment with Y-27638 significantly reduced pHi recovery in a concentration-dependent manner in both groups (Fig. 2C). The sensitivity to the drug in young SHR was similar to that in young WKY rats (Fig. 2C).
Basolateral NHE Activity Is Suppressed by the Inhibition of Rho-Kinase Activity. Removal of Na from bath-induced pHi recovery to the same extent in proximal tubules from adult WKY rats (0.34 ± 0.05 pH units, n = 21) and SHR (0.36 ± 0.06 pH units, n = 22). Pretreatment with Y-27632 significantly suppressed the change of pHi in a concentration-dependent manner (Fig. 3). The sensitivity of the two groups did not differ significantly. In young animals, the recovery of pHi after Na removal and the sensitivity to Y-27632 were similar to those of adult rats (Fig. 3).
|
Y-27632 Increases Sodium Excretion and Urinary Volume at a Subdepressor Dose. In WKY rats, the systemic infusion of Y-27632 at a subdepressor dose significantly increased urinary volume, urinary Na excretion, and FE Na, whereas GFR and FE K were not influenced (Table 1). Vehicle alone did not change any parameters. In SHR, urine volume at basal condition was not different from that in WKY. Basal FE Na in SHR was significantly lower than that of WKY rat (0.26 ± 0.06 versus 0.40 ± 0.05%, P = 0.04), but total Na excretion during control period was not significantly lower than that in WKY rat (0.034 ± 0.009 versus 0.052 ± 0.007 mEq/h/100 g b.wt., P = 0.08). After the addition of Y-27632, urinary volume, Na excretion, and FE Na significantly increased in both groups of rats (Table 1). The changes of Na excretion and FE Na were greater in SHR, whereas the change of urinary volume of the two groups did not differ significantly. There were no changes in FE K induced by Y-27632. Mean arterial pressure during the experiments is listed in Table 1. Although mean arterial pressure in SHR was significantly higher than that in age-matched WKY rats, it was not changed by Y-27632 treatment in either group.
|
22Na Uptake of BBMV Was Decreased by Treatment of Y-27632. 22Na uptake of BBMV treated with vehicle was significantly higher in adult SHR than age-matched WKY (0.72 ± 0.24 and 1.37 ± 0.30 nmol/mg/5 s, WKY and SHR, respectively; n = 4 each, P < 0.05). In BBMV treated with Y-27632 in vivo, the uptake was significantly (P < 0.05) lower than that treated with vehicle (0.46 ± 0.19 and 0.59 ± 0.27 nmol/mg/5 s, WKY and SHR, respectively; n = 4 in each). In young animals, the uptake was not significantly different between SHR and WKY (0.60 ± 0.14 and 0.55 ± 0.18 nmol/mg/5 s, WKY and SHR, respectively; n = 4 in each). Y-27632 inhibited the uptake to a similar extent in both groups (0.43 ± 0.15 and 0.41 ± 0.12 nmol/mg/5 s, WKY and SHR, respectively; n = 4 each). These results further supported our data with in vitro microperfusion that apical NHE activity was reduced by inhibition of Rho-kinase.
| Discussion |
|---|
|
|
|---|
We also compared the renal NHE activities in SHR with those in WKY rats.
Compared with proximal tubules from WKY rats, there was increased NHE3
activity in tubules from SHR. These findings are compatible with previous
results; Morduchowicz et al.,
1989
; Dagher and Sauterey,
1992
; Hayashi et al.,
1997
). Furthermore, we showed that the sensitivity of the enhanced
NHE3 activity in proximal tubules was about 50-fold higher in SHR compared
with WKY rats. Because NHE3 mRNA expression is not different between SHR and
WKY kidneys (Hayashi et al.,
1997
), the higher NHE3 activity in proximal tubules of SHR may be
attributable to the special conditions of anchoring NHE3 to the apical
membrane by the actin cytoskeleton of SHR. In aortic endothelium, stress fiber
expression was more prominent in SHR than in WKY
(White and Fujiwara, 1986
).
This may also be true in renal cells. Further studies, such as the evaluation
of p160ROCK expression, are needed to address these differences.
It has also been reported that dpHi/dt after
prepulse is mediated largely by NHE
activity, but also by vacuolar H-ATPase activity in the apical membrane of
proximal convoluted tubules (Dagher and
Sauterey, 1992
; Aldred et al.,
2000
). For this reason, we preincubated proximal tubules with
luminal bafilomycin A1, a specific inhibitor of the vacuolar H-ATPase
(Tsuruoka and Schwartz, 1997
),
so that only sodium-dependent changes in pHi were evaluated after
acid loading the tubules.
Another important finding of this study is that administration of Y-27632
using a subdepressor dose enhanced Na excretion and total urine volume. These
clearance results are compatible with the data obtained from our in vitro
microperfusion study. Systemic infusion of this drug at a higher dose reduces
arterial blood pressure by inhibiting NHE1 in vascular smooth muscle cell
(Hirata et al., 1992
;
Uehata et al., 1997
), which
leads to a reduction of renal blood flow and subsequent increase in Na
absorption and decrease in urine volume. To evaluate a more specific renal
tubular response to this drug, we titrated its dose such that there was no
change in blood pressure; under these conditions, we performed the renal
clearance study. In general, a natriuresis, especially in patients with
hypertension, reduces the blood pressure. Our findings suggest that the
natriuresis induced by Y-27632 may contribute to the blood pressure lowering
effect of this agent. Although the exact site of action of the drug in the
kidney is uncertain, the proximal tubule may be one of the sites because the
drug did not change urinary K excretion. We also found that urinary Na
excretion induced by Y-27632 via the inhibition of Rho-kinase is more
prominent in SHR than in WKY rats. This is in good agreement with our in vitro
findings herein. Increases in FE Na and total Na excretion were higher in SHR,
whereas changes in urine volume were similar in both strains. Basal FE Na was
lower in SHR, which is compatible with previous results
(Khraibi and Knox, 1989
).
In conclusion, we have found that the inhibition of Rho-kinase (which may lead to the disruption of the actin cytoskeleton) reduced the activity of NHE in both apical and basolateral membranes of the native rat renal proximal convoluted tubule. The sensitivity in vitro was higher in adult SHR than in WKY, whereas such a difference was not observed in young animals. In vivo infusion of Y-27632 at a subdepressor dose enhanced urinary volume and Na excretion without affecting the GFR in both strains. The natriuresis was more prominent in SHR than in WKY rats. Thus, the normal actin network in renal proximal convoluted tubule cells is required to maintain NHE activity and urinary Na excretion. The network may be altered in SHR, thereby contributing to salt retention and hypertension. These findings may provide new clues toward better understanding the mechanisms of essential hypertension.
| Acknowledgements |
|---|
| Footnotes |
|---|
ABBREVIATIONS: NHE, sodium-hydrogen exchanger; SHR, spontaneously hypertensive rat; Y-27632, (R)-(+)-trans-N-(4-pyridyl)-4-(1-amino-ethyl)-cyclohexanecarboxamide; WKY, Wistar Kyoto; BP, blood pressure; BCECF-AM, acetoxymethyl ester of 2',7'-bis(carboxyethyl) carboxyfluorescein; FE, fractional excretion; GFR, glomerular filtration rate; BBMV, brush-border membrane vesicle; MES, 4-morpholineethanesulfonic acid; CHO, Chinese hamster ovary.
Address correspondence to: Dr. Shuichi Tsuruoka, Department of Clinical Pharmacology, Jichi Medical School, 3311 Yakushiji, Minamikawachi, Kawachi, Tochigi 329-0498, Japan. E-mail: tsuru{at}jichi.ac.jp
| References |
|---|
|
|
|---|
Aldred KL, Harris PJ, and Eitle E (2000) Increased proximal tubule NHE-3 and H+-ATPase activities in spontaneously hypertensive rats. J Hypertens 18: 623628.[Medline]
Alpern R and Rector F (1996) Renal acidification mechanisms, in Brenner and Rector's the Kidney (Brenner B ed) pp 408471, WB Saunders, Philadelphia.
Burg M, Grantham J, Abramow M, and Orloff J (1966)
Preparation and study of fragments of single rabbit nephrons. Am J
Physiol 210:
12931298.
Chalumeau C, du Cheyron D, Defontaine N, Kellermann O, Paillard M,
and Poggioli J (2001) NHE3 activity and trafficking depend on the
state of actin organization in proximal tubule. Am J Physiol Renal
Physiol 280:
F283F290.
Dagher G and Sauterey C (1992) H+ pump and Na+-H+ exchange in isolated single proximal tubules of spontaneously hypertensive rats. J Hypertens 10: 969978.[Medline]
Geibel J, Giebisch G, and Boron WF (1989) Basolateral sodium-coupled acid-base transport mechanisms of the rabbit proximal tubule. Am J Physiol 257: F790F797.
Hall A (1998) Rho GTPases and the actin cytoskeleton.
Science (Wash DC) 279:
509514.
Hamm-Alvarez SF and Sheetz MP (1998)
Microtubule-dependent vesicle transport: modulation of channel and transporter
activity in liver and kidney. Physiol Rev
78:
11091129.
Hayashi M, Yoshida T, Monkawa T, Yamaji Y, Sato S, and Saruta T (1997) Na+/H+-exchanger 3 activity and its gene in the spontaneously hypertensive rat kidney. J Hypertens 15: 4348.[Medline]
Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y,
Seki H, Saida K, and Takai Y (1992) Involvement of rho p21 in the
GTP-enhanced calcium ion sensitivity of smooth muscle contraction.
J Biol Chem 267:
87198722.
Kaplan N (1998) Primary hypertension: pathogenesis, in Clinical Hypertension, pp 41100, Williams & Wilkins, Baltimore.
Kawaguchi A, Ohmori M, Harada K, Tsuruoka S, Sugimoto K, and Fujimura A (2000) The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur J Pharmacol 403: 203208.[CrossRef][Medline]
Kawaguchi A, Sugimoto K, and Fujimura A (2001) Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephro-toxicity. Life Sci 68: 11811190.[CrossRef][Medline]
Khraibi AA and Knox FG (1989) Effect of acute renal decapsulation on pressure natriuresis in SHR and WKY rats. Am J Physiol 257: F785F789.
Kurashima K, D'Souza S, Szaszi K, Ramjeesingh R, Orlowski J, and
Grinstein S (1999) The apical Na+/H+
exchanger isoform NHE3 is regulated by the actin cytoskeleton. J
Biol Chem 274:
2984329849.
Mills JW, Schwiebert EM, and Stanton BA (1994) The cytoskeleton and membrane transport. Curr Opin Nephrol Hypertens 3: 529534.[Medline]
Morduchowicz GA, Sheikh-Hamad D, Jo OD, Nord EP, Lee DB, and Yanagawa N (1989) Increased Na+/H+ antiport activity in the renal brush border membrane of SHR. Kidney Int 36: 576581.[Medline]
Orlowski J, Kandasamy RA, and Shull GE (1992)
Molecular cloning of putative members of the Na/H exchanger gene family. cDNA
cloning, deduced amino acid sequence and mRNA tissue expression of the rat
Na/H exchanger NHE-1 and two structurally related proteins. J Biol
Chem 267:
93319339.
Rose D (1994) Regulation of the effective circulating volume, in Clinical Physiology of Acid-Base and Electrolyte Disorders, pp 235260, McGraw-HIll, Inc., New York.
Shrode LD, Klein JD, O'Neill WC, and Putnam RW (1995) Shrinkage-induced activation of Na+/H+ exchange in primary rat astrocytes: role of myosin light-chain kinase. Am J Physiol 269: C257C266.
Szaszi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S,
and Orlowski J (2000) RhoA and rho kinase regulate the epithelial
Na+/H+ exchanger NHE3. Role of myosin light chain
phosphorylation. J Biol Chem
275:
2859928606.
Takeda M, Yoshitomi K, and Imai M (1993) Regulation of Na+-3HCO3- cotransport in rabbit proximal convoluted tubule via adenosine A1 receptor. Am J Physiol 265: F511F519.
Thomas J, Buschsbaum R, Zimniak A, and Racker E (1979) Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectrometric probes generated in situ. Biochemistry 18: 22102218.[CrossRef][Medline]
Tsuruoka S and Schwartz GJ (1997) Metabolic acidosis stimulates H+ secretion in the rabbit outer medullary collecting duct (inner stripe) of the kidney. J Clin Investig 99: 14201431.[Medline]
Tsuruoka S, Sugimoto KI, Fujimura A, Imai M, Asano Y, and Muto S
(2001) P-Glycoprotein-mediated drug secretion in mouse proximal
tubule perfused in vitro. J Am Soc Nephrol
12:
177181.
Tsuruoka S, Sugimoto K, Muto S, Nomiyama K, Fujimura A, and Imai M
(2000) Acute effect of cadmium-metallothionein on glucose and
amino acid transport across the apical membrane of the rabbit proximal tubule
perfused in vitro. J Pharmacol Exp Ther
292:
769777.
Tsuruoka S, Takeda M, Yoshitomi K, and Imai M (1993) Cellular heterogeneity of ammonium ion transport across the basolateral membrane of the hamster medullary thick ascending limb of Henle's loop. J Clin Investig 92: 18811888.
Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond) 389: 990994.[CrossRef][Medline]
White GE and Fujiwara K (1986) Expression and
intracellular distribution of stress fibers in aortic endothelium.
J Cell Biol 103:
6370.
Yamori Y (1974) Importance of genetic factors in
stroke: an evidence obtained by selective breeding of stroke-prone and
-resistant SHR. Jpn Circ J
38:
10951100.[Medline]
This article has been cited by other articles:
![]() |
X. Yang, H.-C. Huang, H. Yin, R. J. Alpern, and P. A. Preisig RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3 Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1054 - F1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Winaver, E. Ovcharenko, I. Rubinstein, K. Gurbanov, P. Pollesello, B. Bishara, A. Hoffman, and Z. Abassi Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2007 - H2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Sylvester The tone of pulmonary smooth muscle: ROK and Rho music? Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L624 - L630. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||